Related Experiment Video
Updated: May 23, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
30-year follow-up of a patient with classic citrullinemia
Nicola Brunetti-Pierri1, Kerri M Lamance, Richard Alan Lewis
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Citrullinemia is a urea cycle defect requiring long-term care with nutritional and pharmacological management. Despite treatment, morbidity and mortality of this disease remain high, and long-term complications include mild to profound mental retardation, seizures, and growth deficiency. We report a 31-year old woman with classic, neonatal-onset citrullinemia who developed progressive hypertrophic cardiomyopathy and cataracts, neither of which has been recognized previously as a complication of the disease or a consequence of long-term drug treatment.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Myocarditis IV: Nursing Management
Kidney Transplant III: Nursing Management
Continuous Renal Replacement Therapy